Your Best Stock
Stocks › MCK

McKesson MCK

US equityMarket cap rank #155Medical Distribution
$877.59
−$2.91 (-0.33%)
Market open · Sep 24, 2:00 pm ET
After hours $880.50 0.00%
Open$888.91
Prev close$880.50
Day range$877.06 – $896.60
Volume252.9K
Market cap$102.32B
P/E (TTM)23.4
Dividend yield0.37%

Earnings

Average move on report day±4.5%last 16 reports
Closed higher7 of 1644% of the time
Best reaction+16.5%
Worst reaction-11.3%

Stock move on the day after each report

-2.6%2024/Q2-4.4%2024/Q3-0.4%2024/Q4-11.3%2025/Q1+10.6%2025/Q2-1.2%2025/Q3+0.5%2025/Q4-5.8%2026/Q1+1.7%2026/Q2+16.5%2026/Q3-2.5%2026/Q4-0.7%2027/Q1
QuarterReport dateTimingImplied moveActual moveVersus implied
2027/Q15 Aug 2026After Market±62.9%-0.67%Within range
2026/Q47 May 2026After Market±50.2%-2.47%Within range
2026/Q34 Feb 2026After Market±42.1%+16.52%Within range
2026/Q25 Nov 2025After Market±31.4%+1.70%Within range
2026/Q16 Aug 2025After Market±33.9%-5.76%Within range
2025/Q48 May 2025After Market±48.6%+0.47%Within range
2025/Q35 Feb 2025After Market±33.9%-1.18%Within range
2025/Q26 Nov 2024After Market±33.9%+10.60%Within range
2025/Q17 Aug 2024After Market±23.1%-11.34%Within range
2024/Q47 May 2024After Market±23.5%-0.39%Within range
2024/Q37 Feb 2024After Market±22.6%-4.40%Within range
2024/Q21 Nov 2023After Market±22.0%-2.61%Within range
2024/Q12 Aug 2023After Market±19.0%+5.34%Within range
2023/Q48 May 2023After Market±15.9%+5.47%Within range
2023/Q31 Feb 2023After Market±13.3%-1.21%Within range
2023/Q21 Nov 2022After Market±19.2%+2.03%Within range

"Implied move" is the size of move the options market was pricing ahead of the report. Move is the stock’s change on the first session after the release.

Where the revenue comes from

Quarter 2027/Q1

By business line

  • North American Pharmaceutical$86.77B 82.3%
  • Oncology & Multispecialty$14.22B 13.5%
  • Medical-Surgical Solutions$2.82B 2.7%
  • Prescription Technology Solutions$1.57B 1.5%

Latest reported quarter: Q1, ended Jun 2026

Revenue$105.38B+7.7% YoY
Operating profit$1.42B+31.2% YoY
Net profit$1.03B+24.2% YoY
Diluted EPS$5.15-17.6% YoY
Free cash flow-$372.00M+66.4% YoY
Operating cash flow-$220.00M

Revenue, last 8 quarters

$93.7BSep '24$95.3BDec '24$90.8BMar '25$97.8BJun '25$103.2BSep '25$106.2BDec '25$96.3BMar '26$105.4BJun '26

Net profit, last 8 quarters

$287.0MSep '24$928.0MDec '24$1.3BMar '25$831.0MJun '25$1.2BSep '25$1.3BDec '25$1.9BMar '26$1.0BJun '26

Profitability & balance sheet

Gross margin3.6%
Operating margin1.7%
Net margin1.1%
Return on assets5.4%
Current ratio0.89
Liabilities / assets101.5%
Cash & investments$5.16B
Total debt$11.41B
Net cash (debt)-$6.25B
Free cash flow / sales1.5%
Scroll to Top